Literature DB >> 35146370

A ten-year retrospective analysis of nocardiosis in a tertiary care center of South-coastal India.

Chandrashekar Udyavara Kudru1, Abishek Kumar2, Kiran Chawla2, Cheshmitha Minnamreddigari2, Nayana Siddalingaiah2, Vasudeva Guddattu3.   

Abstract

Nocardiosis is an uncommon life-threatening infection caused by Nocardia spp. This study aimed to review the distribution of risk factors, clinical characteristics, microbiological findings, treatment and outcome of patients diagnosed with nocardiosis. This study was a retrospective case record review of all nocardiosis cases that were diagnosed at our tertiary care hospital from January 2008 to December 2019. A total of 48 patients with a mean age of 52.2±16.28 years were included. Out of which forty one (85%) were diagnosed as pulmonary nocardiosis and seven (14.6%) as disseminated disease. Chronic lung disease 25 (52.1%), long term steroid use 22 (45.8%) followed by diabetes mellitus 11 (22.9%) were common predisposing factors. The common symptoms were fever (87.5%), cough (79.2%) and breathlessness (52.1%). The most frequent radiologic finding included consolidation in 38 (79.1%), cavitation with thickened wall in 2 (4.1%), reticulonodular shadows in 2 (4.1%), and unilateral pleural effusion in 5 (10.4%). Nocardia otitidiscaviarum (22.9%) was frequently isolated from cultures. Resistance to trimethoprim-sulfamethoxazole (TMP-SMX) was observed in 21% cases. Mortality was noted in 6 (12.5%) patients and all were with pulmonary involvement. The percentage of death among those with and without pulmonary tuberculosis was 33.3% and 5% respectively. Patients affected by pulmonary nocardiosis with previous history of pulmonary tuberculosis showed significant association with poor outcome (p-value=0.05). In conclusion, nocardiosis mainly affects patients with structural lung disease or immunocompromised hosts with adverse outcome. Awareness of this infection is crucial for a clinician, and any suspicion should lead to make an early diagnosis and choose an appropriate empirical treatment to improve the outcome in this population.
Copyright © 2016 - 2021 InfezMed.

Entities:  

Keywords:  Nocardia spp.; immunocompromised; pulmonary nocardiosis

Year:  2021        PMID: 35146370      PMCID: PMC8805478          DOI: 10.53854/liim-2904-14

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  27 in total

1.  Nocardia species infections in a large county hospital in Miami: 6 years experience.

Authors:  José G Castro; Luis Espinoza
Journal:  J Infect       Date:  2006-09-18       Impact factor: 6.072

Review 2.  Disseminated nocardiosis caused by Nocardia elegans: a case report and review of the literature.

Authors:  Yi You; Wenchief Chen; Baiyu Zhong; Ziqiang Song; Xichuan Yang
Journal:  Infection       Date:  2018-05-08       Impact factor: 3.553

Review 3.  Nocardiosis.

Authors:  P I Lerner
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

Review 4.  Pulmonary nocardiosis in Western Europe-Clinical evaluation of 43 patients and population-based estimates of hospitalization rates.

Authors:  Sebastian R Ott; N Meier; Martin Kolditz; Torsten T Bauer; Gernot Rohde; Elisabeth Presterl; Dirk Schürmann; Philipp M Lepper; Felix C Ringshausen; Holger Flick; Stephen L Leib; Mathias W Pletz
Journal:  Int J Infect Dis       Date:  2019-01-15       Impact factor: 3.623

Review 5.  Nocardiosis: updates and clinical overview.

Authors:  John W Wilson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

6.  Pulmonary nocardiosis due to Nocardia otitidiscaviarum in an immunocompetent host- a rare case report.

Authors:  Kusugodlu Ramamoorthi; Baise Chandrappagouda Pruthvi; Neeleshwara Radhakrishna Rao; Jayaprakash Belle; Kiran Chawla
Journal:  Asian Pac J Trop Med       Date:  2011-06-22       Impact factor: 1.226

Review 7.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 8.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

9.  Pulmonary nocardiosis: risk factors and outcomes.

Authors:  Raquel Martínez Tomás; Rosario Menéndez Villanueva; Soledad Reyes Calzada; Maruja Santos Durantez; José Manuel Vallés Tarazona; Manuel Modesto Alapont; Miguel Gobernado Serrano
Journal:  Respirology       Date:  2007-05       Impact factor: 6.424

Review 10.  Nocardiosis: updated clinical review and experience at a tertiary center.

Authors:  J Ambrosioni; D Lew; J Garbino
Journal:  Infection       Date:  2010-03-20       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.